Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia.

Punwani N, Merin N, Mohrbacher A, Yaghmour G, Sano A, Ramezani L, Chaudhary PM, Ramsingh G.

Leuk Res Rep. 2018 Feb 10;9:18-20. doi: 10.1016/j.lrr.2018.02.002. eCollection 2018.

2.

Development and characterization of a novel luciferase based cytotoxicity assay.

Matta H, Gopalakrishnan R, Choi S, Prakash R, Natarajan V, Prins R, Gong S, Chitnis SD, Kahn M, Han X, Chaudhary V, Soni A, Sernas J, Khan P, Wang D, Chaudhary PM.

Sci Rep. 2018 Jan 9;8(1):199. doi: 10.1038/s41598-017-18606-1.

3.

Mapping the Glyco-Gold Nanoparticles of Different Shapes Toxicity, Biodistribution and Sequestration in Adult Zebrafish.

Sangabathuni S, Murthy RV, Chaudhary PM, Subramani B, Toraskar S, Kikkeri R.

Sci Rep. 2017 Jun 26;7(1):4239. doi: 10.1038/s41598-017-03350-3.

4.

Understanding carbohydrate-protein interactions using homologous supramolecular chiral Ru(ii)-glyconanoclusters.

Bavireddi H, Vasudeva Murthy R, Gade M, Sangabathuni S, Chaudhary PM, Alex C, Lepenies B, Kikkeri R.

Nanoscale. 2016 Dec 1;8(47):19696-19702.

PMID:
27874116
5.

Glyco-gold nanoparticle shapes enhance carbohydrate-protein interactions in mammalian cells.

Sangabathuni S, Vasudeva Murthy R, Chaudhary PM, Surve M, Banerjee A, Kikkeri R.

Nanoscale. 2016 Jul 7;8(25):12729-35. doi: 10.1039/c6nr03008d. Epub 2016 Jun 9.

PMID:
27279022
6.

Assessing the effect of different shapes of glyco-gold nanoparticles on bacterial adhesion and infections.

Chaudhary PM, Sangabathuni S, Murthy RV, Paul A, Thulasiram HV, Kikkeri R.

Chem Commun (Camb). 2015 Nov 7;51(86):15669-72. doi: 10.1039/c5cc05238f.

PMID:
26359971
7.

Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.

Gopalakrishnan R, Matta H, Tolani B, Triche T Jr, Chaudhary PM.

Oncogene. 2016 Apr 7;35(14):1797-810. doi: 10.1038/onc.2015.245. Epub 2015 Jun 29.

8.

A rationally designed peptidomimetic biosensor for sialic acid on cell surfaces.

Chaudhary PM, Murthy RV, Yadav R, Kikkeri R.

Chem Commun (Camb). 2015 May 11;51(38):8112-5. doi: 10.1039/c5cc01662b. Epub 2015 Apr 14.

PMID:
25868668
9.

DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections.

Liu CC, Tseng YT, Li W, Wu CY, Mayzus I, Rzhetsky A, Sun F, Waterman M, Chen JJ, Chaudhary PM, Loscalzo J, Crandall E, Zhou XJ.

Nucleic Acids Res. 2014 Jul;42(Web Server issue):W137-46. doi: 10.1093/nar/gku412. Epub 2014 Jun 3.

10.
11.

A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.

Gopalakrishnan R, Matta H, Chaudhary PM.

Clin Cancer Res. 2013 Sep 15;19(18):5016-26. doi: 10.1158/1078-0432.CCR-12-3510. Epub 2013 Jul 23.

12.

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.

Tolani B, Gopalakrishnan R, Punj V, Matta H, Chaudhary PM.

Oncogene. 2014 May 29;33(22):2928-37. doi: 10.1038/onc.2013.242. Epub 2013 Jun 24.

13.

Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation.

Graham C, Matta H, Yang Y, Yi H, Suo Y, Tolani B, Chaudhary PM.

J Virol. 2013 Feb;87(4):2242-52. doi: 10.1128/JVI.01393-12. Epub 2012 Dec 12.

14.

Hybrid molecules of carvacrol and benzoyl urea/thiourea with potential applications in agriculture and medicine.

Pete UD, Zade CM, Bhosale JD, Tupe SG, Chaudhary PM, Dikundwar AG, Bendre RS.

Bioorg Med Chem Lett. 2012 Sep 1;22(17):5550-4. doi: 10.1016/j.bmcl.2012.07.017. Epub 2012 Jul 14.

PMID:
22850211
15.

A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma.

Punj V, Matta H, Chaudhary PM.

PLoS One. 2012;7(5):e37498. doi: 10.1371/journal.pone.0037498. Epub 2012 May 18.

16.

Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.

Matta H, Gopalakrishnan R, Graham C, Tolani B, Khanna A, Yi H, Suo Y, Chaudhary PM.

PLoS One. 2012;7(5):e36601. doi: 10.1371/journal.pone.0036601. Epub 2012 May 8.

17.

Chitin synthase inhibitors as antifungal agents.

Chaudhary PM, Tupe SG, Deshpande MV.

Mini Rev Med Chem. 2013 Feb;13(2):222-36. Review.

PMID:
22512590
18.

Constitutive NF-kappaB activation confers interleukin 6 (IL6) independence and resistance to dexamethasone and Janus kinase inhibitor INCB018424 in murine plasmacytoma cells.

Yang Y, Groshong JS, Matta H, Gopalakrishnan R, Yi H, Chaudhary PM.

J Biol Chem. 2011 Aug 12;286(32):27988-97. doi: 10.1074/jbc.M110.213363. Epub 2011 Jun 24.

19.

A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.

Matta H, Gopalakrishnan R, Punj V, Yi H, Suo Y, Chaudhary PM.

J Biol Chem. 2011 Jun 17;286(24):21555-64. doi: 10.1074/jbc.M111.224048. Epub 2011 Apr 29.

20.

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU.

Future Microbiol. 2010 Sep;5(9):1349-65. doi: 10.2217/fmb.10.105. Review.

Supplemental Content

Loading ...
Support Center